Question 1

How many shares of ALPN does Connor, Clark & Lunn Investment Management Ltd. own?

Accepted Answer

Connor, Clark & Lunn Investment Management Ltd. previously held 0 shares of ALPN (ALPINE IMMUNE SCIENCES INC) before exiting the position in 2024-Q2.

Question 2

What is Connor, Clark & Lunn Investment Management Ltd.'s ALPN position worth?

Accepted Answer

Connor, Clark & Lunn Investment Management Ltd.'s ALPN position was last reported at $0 in 2024-Q2 before the exit.

Question 3

Is Connor, Clark & Lunn Investment Management Ltd. buying or selling ALPN?

Accepted Answer

In 2024-Q2, Connor, Clark & Lunn Investment Management Ltd. exited their ALPN position entirely (-100.0% change in shares).

Question 4

When did Connor, Clark & Lunn Investment Management Ltd. first buy ALPN?

Accepted Answer

Based on available 13F filings, Connor, Clark & Lunn Investment Management Ltd. first reported a position in ALPN in 2021-Q4. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q1	Increased	13,357	+12.2%	$529,471	0.0%	—	27
2023-Q4	Decreased	11,909	-73.8%	$226,986	0.0%	—	0
2023-Q3	Decreased	45,475	-2.4%	$520,689	0.0%	—	0
2023-Q2	Decreased	46,593	-14.1%	$478,976	0.0%	—	0
2023-Q1	Decreased	54,237	-7.0%	$418,710	0.0%	—	0
2022-Q4	Increased	58,308	+1.4%	$428,564	0.0%	—	24
2022-Q3	Increased	57,506	+14.6%	$414,000	0.0%	—	27
2022-Q2	Increased	50,189	+77.3%	$427,000	0.0%	—	36
2022-Q1	Increased	28,316	+48.8%	$254,000	0.0%	—	32
2021-Q4	New	19,026	-	$264,000	0.0%	—	32

ALPN11 quarters

ALPN
11 quarters